// App-Quantinova.ai

942 : HPK1, hematopoietic progenitor kinase 1, is a promising therapeutic target for cancer immunotherapy

Researchers

Presenter

  • David Ciccone

Principal Investigators

  • Jennifer Rocnik

  • Vad Lazari

  • Ian Linney

  • Michael Briggs

  • Alan Collis

  • Christine Loh

  • Mark Ashwell

  • John Montana

  • Peter Tummino

  • Neelu Kaila

Medical Centers

  • Jounce Therapeutics, Cambridge, MA

  • Charles River Laboratories, Chesterford Research Park, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Pharmacodynamics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved